ACCESS Newswire
04 Feb 2023, 01:01 GMT+10
SAN FRANCISCO, CA / AACCESSWIRE / February 3, 2023 / Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ:FATE) investors who suffered significant losses to submit your losses now.
Class Period: Apr. 2, 2020 - Jan. 5, 2023
Lead Plaintiff Deadline: Mar. 22, 2023
Visit: https://www.hbsslaw.com/investor-fraud/FATE
Contact An Attorney Now: [email protected]
844-916-0895
Fate Therapeutics, Inc. (FATE) Securities Fraud Class Action:
The litigation focuses on Fate's widely touted April 2020 collaboration agreement with Janssen Biotech, pursuant to which Janssen and Fate agreed to collaborate to develop iPSC-derived CAR-NK and CAR T-cell product candidates for the treatment of cancer. Under this agreement, Fate received a $50 million up front payment and was eligible to receive up to $3 billion in various milestone payments and royalties.
According to the complaint, Defendants made materially misleading statements and failed to disclose that: (1) the Janssen agreement was less sustainable than Fate represented to investors; (2) accordingly, certain clinical programs, milestone payments, and royalty payments associated with the agreement could not be relied upon as future revenue sources; and (3) as a result, Fate overstated the impact of the Janssen agreement on Fate's long-term clinical and commercial profitability.
The truth emerged on Jan. 5, 2023, when Fate announced that it terminated the Janssen collaboration agreement after Fate declined Janssen's proposal to continue the agreement on revised terms. The company also said that all collaboration activities with Janssen will be wound down during Q1 2023 and that it is slashing its workforce from 545 (as of Sept. 30, 2022) to about 220 in Q1 2023.
This news resulted in a wave of analyst downgrades and drove the price of Fate Therapeutics shares down over 60% in a single day.
'We're focused on investors' losses and proving Fate misled investors about the strength of- and prospects for- its work with Janssen,' said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Fate Therapeutics and have significant losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.
Whistleblowers: Persons with non-public information regarding Fate Therapeutics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
# # #
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contact:
Reed Kathrein, 844-916-0895
SOURCE: Hagens Berman Sobol Shapiro LLP
Get a daily dose of Cleveland Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Cleveland Star.
More InformationNEW YORK CITY, New York: Former British prime minister Rishi Sunak will return to Goldman Sachs in an advisory role, the Wall Street...
LONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
NEW YORK CITY, New York: Financial markets kicked off the week on a cautious note as President Donald Trump rolled out a fresh round...
RIO DE JANEIRO, Brazil: At a two-day summit over the weekend, the BRICS bloc of emerging economies issued a joint declaration condemning...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
(Photo credit: Kamil Krzaczynski-Imagn Images) Kyle Manzardo was slated to bat cleanup and play first base for the Cleveland Guardians...
(Photo credit: Jerome Miron-Imagn Images) The Miami Marlins and Baltimore Orioles have been counted out for much of the past couple...
(Photo credit: Alex Gallardo-Imagn Images) The Seattle Sounders will be without their captain when they travel to Kansas City, Kan....
(Photo credit: Kamil Krzaczynski-Imagn Images) Thursday evening's contest between the host Chicago White Sox and Cleveland Guardians...
(Photo credit: Katie Stratman-Imagn Images) Nick Lodolo and four relievers combined on a four-hit shutout Thursday for the host Cincinnati...